Sayer Ji, Contributor
Could the active ingredient in marijuana, responsible for its characteristic “high,” help
turn the tide against the accelerating Alzheimer’s epidemic?
A remarkable study published in the journal Molecular Pharmacology in 2006, found that this long-vilified plant contains a compound with not one, but two therapeutic properties ideal for addressing both the surface symptom (memory problems) and root cause (brain plaque) of Alzheimer’s disease. This is an ironic finding, considering that the prevailing stereotype is that using marijuana “fries” the brain, leading to debilitating memory issues.
Researchers discovered that the psychoactive component of marijuana, Δ9-tetrahydrocannabinol (THC), both “competitively inhibits the enzyme acetylcholinesterase (AChE) as well as prevents AChE-induced amyloid β-peptide (Aβ) aggregation.”